HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protection by methyl inosine monophosphate (MIMP) against aerosol influenza virus infection in mice.

Abstract
Methyl inosine monophosphate (MIMP) is a novel thymomimetic purine immunomodulator capable of enhancing a wide variety of immune responses. Intravenous (i.v.) administration of MIMP 1 day prior to influenza virus infection could confer partial protection and significantly increase the mean survival of treated mice. Intranasal (i.n.) administration of MIMP improved survival rates and incorporation of MIMP in squalane-saline emulsion 1 day prior to or 1 h after influenza infection conferred complete protection. Mice administered MIMP had reduced levels of lung virus and lower titers of circulating serum hemagglutination-inhibition (HI) antibodies. Complete survival and reduction of viral load after influenza challenge infection suggests effective stimulation by MIMP of protective responses against influenza virus.
AuthorsK Noel Masihi, John W Hadden
JournalInternational immunopharmacology (Int Immunopharmacol) Vol. 2 Issue 6 Pg. 835-41 (May 2002) ISSN: 1567-5769 [Print] Netherlands
PMID12095174 (Publication Type: Journal Article)
Chemical References
  • Aerosols
  • Inosine Monophosphate
  • methyl inosine monophosphate
Topics
  • Aerosols
  • Animals
  • Female
  • Influenza A virus (drug effects)
  • Inosine Monophosphate (analogs & derivatives, pharmacology, therapeutic use)
  • Mice
  • Orthomyxoviridae Infections (blood, drug therapy, mortality, prevention & control)
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: